Syfovre Dosage Guide: Understanding Your Treatment for Geographic Atrophy

Geographic atrophy (GA) is a severe, advanced form of dry age-related macular degeneration (AMD) that leads to irreversible vision loss. It's a progressive condition that damages the macula, the part of the retina responsible for sharp, central vision. Until recently, there were no approved treatments specifically for GA. The introduction of Syfovre (pegcetacoplan) represents a significant advancement, offering a new therapeutic option to slow the progression of this debilitating disease.

Understanding the correct dosage and administration of Syfovre is crucial for patients undergoing this treatment. This comprehensive guide will delve into what Syfovre is, how it works, its recommended dosage, administration details, and other vital information to help you navigate your treatment journey with confidence.

What is Syfovre (Pegcetacoplan)?

Syfovre is a prescription medication used to treat geographic atrophy secondary to age-related macular degeneration. Its active ingredient, pegcetacoplan, is a targeted C3 complement inhibitor. The complement system is a part of the body's immune response, and in GA, it's believed to be overactive, contributing to the degeneration of retinal cells.

By inhibiting C3, Syfovre aims to slow down the progression of GA, thereby preserving vision for a longer period. It's important to note that Syfovre does not cure GA or restore vision that has already been lost, but rather works to slow the rate of lesion growth.

Understanding Geographic Atrophy (GA)

Geographic atrophy is characterized by patches of atrophy (wasting away) of the retinal pigment epithelium (RPE), photoreceptors, and choroid in the macula. This leads to blind spots or blurred central vision, making activities like reading, driving, and recognizing faces increasingly difficult. GA typically affects older adults and can progress at varying rates in different individuals.

The exact cause of GA is complex and multifactorial, involving genetic predispositions, environmental factors, and age-related changes. The complement system has been identified as a key player in the inflammatory and degenerative processes seen in GA.

Recommended Syfovre Dosage and Administration

Standard Dosage

The recommended dosage of Syfovre is 15 mg (0.1 mL of 150 mg/mL solution) administered by intravitreal injection into each affected eye once every 25 to 60 days. Your ophthalmologist will determine the precise schedule based on your individual condition and response to treatment.

• Dose: 15 mg (0.1 mL) per eye
• Method: Intravitreal injection
• Frequency: Once every 25 to 60 days

It is critical to adhere to the prescribed dosing schedule to maximize the therapeutic benefits of Syfovre and ensure consistent suppression of the complement system.

How Syfovre is Administered

Syfovre is administered directly into the vitreous humor (the jelly-like substance filling the eye) by a qualified ophthalmologist. This procedure is called an intravitreal injection. The process typically involves:

1. Preparation: Before the injection, the eye and surrounding area will be cleaned with an antiseptic solution to minimize the risk of infection. Topical anesthetic eye drops or gel will be applied to numb the eye, making the procedure more comfortable.
2. Injection: The ophthalmologist will use a very fine needle to inject Syfovre into the eye. Patients may feel slight pressure but generally no pain during the injection itself.
3. Post-Injection Care: After the injection, the doctor may check your eye pressure. You will receive specific instructions for post-injection care, which may include avoiding rubbing your eye and watching for any signs of infection or complications.

It is normal to experience some mild discomfort, redness, or a feeling of something in the eye immediately after the injection. These symptoms usually subside within a day or two.

What Happens If You Miss a Dose?

If you miss an appointment for a Syfovre injection, it is important to contact your ophthalmologist's office as soon as possible to reschedule. Missing doses or delaying injections can impact the effectiveness of the treatment in slowing GA progression.

Your doctor will advise you on the best course of action, which typically involves administering the missed dose as soon as feasible and then adjusting subsequent doses to maintain an optimal treatment schedule.

What If You Receive Too Much Syfovre (Overdose)?

Since Syfovre is administered by a healthcare professional in a controlled clinical setting, an overdose is highly unlikely. However, if there were any concerns about the amount administered, your ophthalmologist would closely monitor your eye for any adverse effects, such as increased intraocular pressure or signs of inflammation.

Always communicate any unusual symptoms or concerns to your healthcare provider immediately.

Syfovre: Important Considerations Before and During Treatment

Who Can Receive Syfovre?

Syfovre is approved for adults with geographic atrophy secondary to age-related macular degeneration. Your ophthalmologist will conduct a thorough examination and review your medical history to determine if Syfovre is an appropriate treatment option for you.

Precautions and Warnings

Before starting Syfovre, discuss your full medical history with your doctor, especially if you have:

• Eye infections: Syfovre should not be given to patients with active eye infections.
• History of eye inflammation: Patients with a history of recurrent eye inflammation may be at higher risk for new or worsening inflammation.
• Glaucoma: Transient increases in intraocular pressure (IOP) can occur after intravitreal injections. Your doctor will monitor your IOP.
• Other eye conditions: Discuss any other eye conditions, surgeries, or treatments you have had.

It is also important to inform your doctor about all medications you are taking, including over-the-counter drugs, vitamins, and herbal supplements.

Potential Side Effects

Like all medications, Syfovre can cause side effects. Some common side effects associated with intravitreal injections and Syfovre include:

• Eye discomfort or pain
• Floaters (specks in your vision)
• Conjunctival hemorrhage (redness from a broken blood vessel in the eye)
• Increased intraocular pressure
• Blurred vision

More serious, though less common, side effects can include:

• Endophthalmitis (severe eye infection): This is a rare but serious complication of any intravitreal injection. Symptoms include severe eye pain, redness, sensitivity to light, and vision loss.
• Retinal detachment: A rare but serious condition where the retina separates from the back of the eye.
• New or worsening inflammation in the eye (vitritis, uveitis): This can lead to vision changes.
• Neovascular AMD (wet AMD): There is an increased risk of developing new or worsening wet AMD in patients treated with Syfovre. Your doctor will monitor for this.

If you experience any severe or persistent side effects, especially sudden changes in vision, severe eye pain, or redness, contact your ophthalmologist immediately.

Pregnancy and Breastfeeding

It is not known if Syfovre can harm an unborn baby or if it passes into breast milk. If you are pregnant, planning to become pregnant, or breastfeeding, discuss the risks and benefits with your doctor before starting treatment.

Monitoring During Treatment

Regular follow-up appointments with your ophthalmologist are essential while on Syfovre treatment. Your doctor will monitor your eye health, check for any side effects, and assess the progression of your geographic atrophy. This may include:

• Visual acuity tests: To check your central vision.
• Optical Coherence Tomography (OCT): To visualize the layers of your retina and assess GA lesion size.
• Fundus photography: To document the appearance of your retina.
• Intraocular pressure (IOP) checks: To monitor for elevated eye pressure.

Consistent monitoring helps ensure the treatment is safe and effective for you.

Adherence and Treatment Success

Adhering strictly to your prescribed Syfovre dosage schedule is paramount for the success of your treatment. Geographic atrophy is a chronic, progressive condition, and consistent complement inhibition is necessary to potentially slow its advancement. Missing injections or extending the time between doses can reduce the effectiveness of the medication, potentially leading to faster disease progression.

If you have concerns about your treatment schedule, or if you anticipate difficulty attending appointments, communicate openly with your healthcare team. They can work with you to find solutions and ensure you receive your treatment as prescribed.

When to See a Doctor

You should contact your ophthalmologist immediately if you experience any of the following symptoms, especially after a Syfovre injection:

• Severe eye pain or increasing pain
• Sudden decrease in vision or significant vision changes
• Severe eye redness or inflammation
• Extreme sensitivity to light
• New or worsening floaters or flashes of light
• Any signs of infection, such as discharge from the eye

These symptoms could indicate a serious complication requiring urgent medical attention.

Frequently Asked Questions (FAQs)

Q1: How long will I need to take Syfovre?

A1: Geographic atrophy is a chronic condition, and treatment with Syfovre is typically long-term. Your ophthalmologist will discuss the expected duration of treatment based on your individual condition and response.

Q2: Can Syfovre restore lost vision?

A2: No, Syfovre is designed to slow the progression of geographic atrophy and prevent further vision loss. It does not restore vision that has already been lost due to GA.

Q3: Is Syfovre painful to receive?

A3: While the idea of an eye injection can be daunting, the procedure is typically well-tolerated. Your eye will be numbed with anesthetic drops or gel, and most patients report feeling only a slight pressure during the injection, rather than pain.

Q4: What should I avoid after a Syfovre injection?

A4: Your doctor will provide specific post-injection instructions. Generally, it's advised to avoid rubbing your eye vigorously and to be mindful of any signs of infection. You may be advised to avoid swimming or using hot tubs for a few days.

Q5: Can I drive myself home after a Syfovre injection?

A5: Your vision may be temporarily blurred or sensitive to light after the injection. It's often recommended to arrange for someone to drive you home, especially after your first few injections, until you know how you react to the procedure.

Conclusion

Syfovre offers a hopeful new treatment option for individuals living with geographic atrophy, a condition that previously had no approved therapies. Adhering to the prescribed dosage and administration schedule is paramount for maximizing the benefits of this medication in slowing the progression of GA. Open communication with your ophthalmologist, diligent monitoring, and prompt reporting of any concerning symptoms are key components of a successful treatment journey.

If you have geographic atrophy or are concerned about your vision, consult with an ophthalmologist to determine if Syfovre or other treatments are appropriate for your condition. Staying informed and actively participating in your care plan will empower you to manage your eye health effectively.